Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
The Hidden Career Cost of Being Overweight
New moves to outlaw weight discrimination are pushing companies to examine one of the most insidious forms of on-the-job bias. Source link
Piper Sandler Maintains Codexis (CDXS) Overweight Recommendation
Fintel reports that on April 17, 2023, Piper Sandler maintained coverage of Codexis (NASDAQ:CDXS) with a Overweight recommendation. Analyst Price Forecast Suggests 201.90% Upside As
Morgan Stanley Maintains Royalty Pharma (RPRX) Overweight Recommendation
Fintel reports that on April 10, 2023, Morgan Stanley maintained coverage of Royalty Pharma (NASDAQ:RPRX) with a Overweight recommendation. Analyst Price Forecast Suggests 48.83% Upside
Barclays Reiterates Diageo (LSE:DGE) Overweight Recommendation
Fintel reports that on April 6, 2023, Barclays reiterated coverage of Diageo (LSE:DGE) with a Overweight recommendation. What are Other Shareholders Doing? EARAX – Eaton
Barclays Reiterates Auto Trader Group (LSE:AUTO) Overweight Recommendation
Fintel reports that on April 6, 2023, Barclays reiterated coverage of Auto Trader Group (LSE:AUTO) with a Overweight recommendation. Analyst Price Forecast Suggests 99.93% Downside
Piper Sandler Reiterates Alteryx (AYX) Overweight Recommendation
Fintel reports that on April 6, 2023, Piper Sandler reiterated coverage of Alteryx (NYSE:AYX) with a Overweight recommendation. Analyst Price Forecast Suggests 48.58% Upside As
Morgan Stanley Maintains American Express (AXP) Overweight Recommendation
Fintel reports that on April 5, 2023, Morgan Stanley maintained coverage of American Express (NYSE:AXP) with a Overweight recommendation. Analyst Price Forecast Suggests 18.44% Upside
Wells Fargo Maintains Acuity Brands (AYI) Overweight Recommendation
Fintel reports that on April 5, 2023, Wells Fargo maintained coverage of Acuity Brands (NYSE:AYI) with a Overweight recommendation. Analyst Price Forecast Suggests 22.46% Upside
JP Morgan Maintains Relay Therapeutics (RLAY) Overweight Recommendation
On April 5, 2023, JP Morgan maintained coverage of Relay Therapeutics with a Overweight recommendation. Analyst Price Forecast Suggests 103.68% Upside As of March 30,
Morgan Stanley Maintains M & T Bank (MTB) Overweight Recommendation
On April 5, 2023, Morgan Stanley maintained coverage of M & T Bank with a Overweight recommendation. Analyst Price Forecast Suggests 51.79% Upside As of